Behind the U.S. Frozen Blueberry Recall:Pathogenesis and Research Frontiers of Listeria monocytogenes

In 2025, multiple foodborne outbreaks caused by Listeria monocytogenes (Lm) were reported across the United States, once again placing this pathogen under intense public health scrutiny. In February 2026, the U.S. Food and Drug Administration (FDA) issued a Class I recall for approximately 56,000 pounds of frozen blueberries produced by an Oregon-based company due to potential Lm contamination. The implicated bulk industrial products had been distributed to Michigan, Oregon, Washington, Wisconsin, and parts of Canada.
As the only major foodborne intracellular pathogen capable of sustained proliferation at 4°C under standard refrigeration, L. monocytogenes remains a primary biological hazard in cold-chain food systems worldwide. Beyond food safety, it is also a canonical model organism in microbiology and infection immunology for dissecting intracellular parasitism and host–pathogen interactions.

I. Pathobiology, Transmission, and Epidemiological Features of Listeria monocytogenes

L. monocytogenes is a Gram-positive, facultative anaerobic rod and the most clinically relevant zoonotic species within the genus Listeria. It is non-spore-forming, lacks a capsule, and exhibits temperature-dependent motility. At 20–25°C, it produces peritrichous flagella and displays active motility; at 37°C, flagellar synthesis is downregulated, reflecting adaptation to the host environment.
A defining physiological characteristic of Lm is its psychrotolerance. It can grow across a broad temperature range (0–45°C) and pH spectrum (4.5–9.0), and it proliferates—albeit slowly—under typical refrigeration conditions (4°C). Additionally, it forms robust biofilms on food-processing equipment surfaces, conferring tolerance to disinfectants and environmental stressors. These features underpin its persistence in cold-chain facilities and its recurrent association with ready-to-eat and frozen products.
Lm is classified into 13 serotypes based on O and H antigens. Among them, serotype 1/2a predominates in both food isolates and clinical cases and serves as a principal laboratory strain background for mechanistic studies. Over 90% of invasive human listeriosis cases worldwide are attributed to serotypes 1/2a and 4b.

Figure 1: Listeria phylogeny

The bacterial cell wall contains a thick peptidoglycan layer anchoring multiple virulence-associated proteins. Notably, IAP/p60, a peptidoglycan hydrolase, is highly conserved and stably expressed among pathogenic Listeria species. It contributes to cell wall remodeling and bacterial morphology and is closely associated with virulence phenotypes. Importantly, IAP serves as a discriminatory marker between pathogenic and non-pathogenic Listeria species.
Lm is widely distributed in soil, water, and the gastrointestinal tracts of animals. Contamination may occur at any point along the agricultural-to-distribution continuum. High-risk categories include frozen produce and ready-to-eat dairy products. Clinically, listeriosis disproportionately affects pregnant women, the elderly, and immunocompromised individuals. Invasive infections in these populations carry case-fatality rates of 20–30%, highlighting the clinical severity of systemic disease.

Figure 2: Clinical presentation and features of listeriosis

II. Molecular Mechanisms Underlying Listeria monocytogenes Virulence

The high pathogenicity of Lm derives from its well-orchestrated facultative intracellular lifecycle. Through coordinated expression of virulence factors, the bacterium executes host cell adhesion and invasion, phagosomal escape, cytosolic replication, and cell-to-cell spread, while evading humoral immune clearance. These processes enable translocation across intestinal, blood–brain, and placental barriers, culminating in invasive disease.
Most core virulence determinants are encoded within Listeria Pathogenicity Island 1 (LIPI-1) and are tightly regulated by the transcriptional activator PrfA, forming a hierarchically controlled virulence network.

Figure 3: Overview of Listeria monocytogenes infection

4. Barrier Penetration and Systemic Dissemination

After breaching the intestinal epithelium, Lm disseminates hematogenously to the liver and spleen. In susceptible hosts, it can further penetrate the blood–brain barrier, causing meningitis or encephalitis, or cross the placental barrier, leading to miscarriage, preterm birth, or neonatal sepsis. The coordinated activity of InlA, InlB, LLO, and ActA, combined with host immune status and strain-specific virulence traits, determines clinical severity.

 

Figure 4: Mechanisms by which L. monocytogenes crosses host barriers